Apoptosis of crypt epithelial cells in ulcerative colitis

Journal of Pathology

Volumn 180, Issue 2, 1996, Pages 152-159

  Iwamoto, Michiko ^a   Koji, Takehiko ^a   Makiyama, Kazuya ^a   Kobayashi, Nobuyuki ^b   Nakane, Paul K ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

apoptosis; cell death; colon; epithelial cell; Fas; Fas ligand; TUNEL; ulcerative colitis

Indexed keywords

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; ULCERATIVE COLITIS; ULTRASTRUCTURE;

ANTIGENS, CD95; APOPTOSIS; BIOPSY; COLITIS, ULCERATIVE; DNA DAMAGE; FAS LIGAND PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MEMBRANE GLYCOPROTEINS; MICROSCOPY, ELECTRON; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0029823381     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199610)180:2<152::AID-PATH649>3.0.CO;2-Y     Document Type: Article

References (30)

1. Gibson PR, Pavli P. Pathogenic factors in inflammatory bowel disease. Dig Dis 1992; 10: 17-28.
2. Shanahan F, Targan SR. Mechanisms of tissue injury in inflammatory bowel disease, In: MacDermott RP, Stenson WF, eds. Inflammatory Bowel Disease. New York: Elsevier, 1992; 77-93.
3. Travis SPL, Jewell DP. Salicytes for ulcerative colitis - their mode of action. Pharmac Ther 1994; 63: 135-161.
4. Gibson PR, Van De Pol E, Barratt PJ, Doe WF. Ulcerative colitis - a disease characterised by the abnormal colonic epithelial cell? Gut 1988; 29: 516-521.
5. Allan A, Bristol JB, Williamson RCN. Crypt cell production rate in ulcerative colitis: differential increments in remission and relapse. Gut 1985; 26: 999-1003.
6. Serafini EP, Kirk AP, Chambers TJ. Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut 1981; 22: 648-652.
7. Lee FD. Importance of apoptosis in the histopathology of drug related lesions in the large intestine. J Clin Pathol 1993; 46: 118-122.
8. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
9. Wyllie AH, Kerr JFK, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytot 1980; 68: 251-306.
10. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
11. Wijsman JH, Jonker RR, Keijzer R, Van De Velde CJH, Cornelisse CJ, Van Dierendonck JH. A new method to detect apoptosis in paraffin sections: in situ end-labelling of fragmented DNA. J Histochem Cytochem 1993; 41: 7-12.
12. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
13. Nakane PK, Pierce GB. Enzyme-labelled antibodies: preparation and application for the localization of antigens. J Histochem Cytochem 1966; 14: 929-931.
14. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-243.
15. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178.
16. Koji T, Kobayashi N, Nakanishi Y, et al. Immunohistochemical localization of Fas in paraffin sections with rabbit antibodies against human synthetic Fas peptides. Acta Histochem Cytochem 1994; 27: 1-5.
17. Hakuno N, Koji T, Yano T, et at. Fas/APO/CD95 system as mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology (in press).
18. Adams JC. Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 1981; 29: 775.
19. Wyllie AH, Morris RG, Smith L, Dunlop D. Cliromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence of macromolecular synthesis. J Pathol 1984; 142: 67-77.
20. Moller P, Koretz K, Leithauser F, et al. Expression of APO-I (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int J Cancer 1994; 57: 371-377.
21. Iwanaga T, Han H, Fujita T. Macrophage possibly involved in the disposal of apoptotic epithelial cells in the monkey small and large intestine. Acta Med Biol 1992; 40: 105-113.
22. Nagata S, Goldstein P. The Fas death factor. Science 1995; 267: 1449-1456.
23. Tysk C, Riedesel H, Lindberg E. Colonic glycoproteins in monozygotic twins with inflammatory bowel disease. Gastroenterology 1991; 100: 419-423.
24. Asakura H, Tsuchiya M, Aiso S, et al. Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis. Gastroenterology 1982; 82: 413-418.
25. Roediger WEW. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet 1980; ii: 712-715.
26. Podolsky DK, Isselbacher KJ. Composition of human colonic mucin. J Clin Invest 1983; 72: 142-153.
27. Lundberg JON, Hellstrom PM, Lundberg JM, Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994; 344: 1673-1674.
28. Nunez G, Clark MF. The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol 1994; 4: 399-403.
29. Madara JL, Stafford J. Interferon-† directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989; 83: 724-727.
30. Mayer M, Noble M. N-acetyl-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci USA 1994; 91: 7496-7500.